Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.2B | 14.7B | 14.8B | 15.0B |
Cost of revenue | 9.9B | 10.2B | 10.4B | 10.2B |
Gross profit | 3.3B | 4.5B | 4.4B | 4.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 496M | 551M | 574M | 626M |
Other operating expenses | 2.3B | 2.4B | 2.3B | 2.2B |
Operating income | 502M | 1.6B | 1.6B | 2.0B |
Non operating interest income | ||||
Income | 164M | 172M | 187M | 190M |
Expense | 308M | 316M | 326M | 367M |
Other income expense | 123M | -120M | -135M | -49M |
Pretax income | 478M | 1.3B | 1.3B | 1.7B |
Tax provision | 91M | 322M | 321M | 416M |
Net income | 387M | 984M | 965M | 1.3B |
Basic EPS | 1.2 | 3.0 | 2.9 | 4.0 |
Diluted EPS | 1.2 | 3.0 | 2.9 | 4.0 |
Basic average shares | 366.3M | 366.7M | 368.0M | 367.7M |
Diluted average shares | 372.4M | 374.1M | 372.1M | 373.4M |
EBITDA | 699M | 1.7B | 1.7B | 2.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |